RBD-BRIDGE™
Framework

One architecture connecting every rare bone disease to measurable outcomes

How RBD-IBI is designed to take each disease from shared skeletal pathology to validated, fit-for-purpose imaging biomarkers.

The RBD-IBI scientific framework

From rare bone disease to measurable outcome.

One transparent pathway is at the heart of what makes RBD-IBI distinctive.

  1. Rare Bone Disease
  2. Shared Skeletal Pathology
  3. RBD–SSP Group Populations
  4. Imaging & Data
  5. Quantitative Imaging Biomarker
  6. Validation
  7. Context of Use · Clinical & Trial Application

RBD-BRIDGE™ is the digital platform that operationalises this framework. Find out more

Programmes

The four scientific pillars.

The scientific architecture of RBD-IBI is built on these four core programmes. Broader activities such as dissemination and training complement, rather than replace, these pillars.

Shared Skeletal Pathology Framework

Programme 01

Define SSPs, terminology and the biological evidence required to establish a shared skeletal pathology.

RBD–SSP Group Populations

Programme 02

Identify and qualify RBDs that genuinely share the same SSP using the biological grouping framework.

Imaging, Data & Repository Infrastructure

Programme 03

Identify, catalogue, govern and connect relevant imaging, datasets, registries, cohorts and other evidence resources.

Imaging Biomarker Development & Validation

Programme 04

Support identification, development and validation of quantitative imaging biomarkers, including Context of Use.

Methodology

Imaging biomarkers at the core.

Quantitative, fit-for-purpose measures of disease are designed to sit at the heart of the initiative — acquired to common protocols, analysed transparently and compared across centres, studies and countries.

See the RBD-BRIDGE™ concept
Governance & ethics

Accountability is part of the design.

Governance, ethics and data protection are designed into the architecture from the start — accountability is a feature, not an afterthought.

Ethics

Independent review and patient voice at every stage.

Data protection

Consent-first, anonymised and auditable.

Reporting

Registered, reproducible and published openly.